Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicentre, Double-blind, Parallel, Sham-controlled Study of gammaCore®, a Non-invasive Vagal Nerve Stimulator (nVNS), for Prevention of Episodic Migraine

NCT02378844 is registered in ClinicalTrials.gov with ElectroCore INC as lead sponsor.

NCT NCT02378844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicentre, Double-blind, Parallel, Sham-controlled Study of gammaCore®, a Non-invasive Vagal Nerve Stimulator (nVNS), for Prevention of Episodic Migraine
Lead sponsor
ElectroCore INC
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2015
Completion date
August 29, 2018
Enrollment
477 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

migraine